Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on therapies for acute ischemic stroke.

D D Kindler1, G A Lopez, B B Worrall

  • 1Department of Neurology, University of Virginia, Charlottesville, Virginia 22908, USA.

Neurosurgical Focus
|July 25, 2006
PubMed
Summary

New therapies for acute ischemic stroke are emerging. Intravenous tissue-type plasminogen activator is FDA-approved, while intra-arterial thrombolytics and other treatments show promise for this neurological emergency.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unraveling Azospirillum's colonization ability through microbiological and molecular evidence.

Journal of applied microbiology·2023
Same author

P97/VCP ATPase inhibitors can rescue p97 mutation-linked motor neuron degeneration.

Brain communications·2022
Same author

Migraine-Associated Common Genetic Variants Confer Greater Risk of Posterior vs. Anterior Circulation Ischemic Stroke☆.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2022
Same author

Detailed phenotyping of posterior vs. anterior circulation ischemic stroke: a multi-center MRI study.

Journal of neurology·2019
Same author

Validation of SenseWear Armband in children, adolescents, and adults.

Scandinavian journal of medicine & science in sports·2017
Same author

Content of cardiolipin of the membrane and sensitivity to cationic surfactants in Pseudomonas putida.

Journal of applied microbiology·2016

Area of Science:

  • Neurology
  • Neurosurgery
  • Vascular Neurology

Background:

  • Acute ischemic stroke is a critical neurological emergency.
  • Advances in treatment necessitate ongoing education for neurologists and neurosurgeons.
  • Current therapeutic options are limited but expanding.

Purpose of the Study:

  • To review approved and emerging therapies for acute ischemic stroke.
  • To inform clinicians about the latest advancements in stroke treatment.
  • To highlight the evolving landscape of acute cerebral ischemia management.

Main Methods:

  • Literature review of recent publications on acute ischemic stroke therapies.
  • Analysis of currently approved treatments.
  • Evaluation of investigational and emerging treatment modalities.

Related Experiment Videos

Main Results:

  • Intravenous tissue-type plasminogen activator is the sole FDA-approved therapy for acute ischemic stroke.
  • Intra-arterial thrombolytic delivery demonstrates potential efficacy in select patient populations.
  • Several other promising therapies for acute cerebral ischemia are currently in investigational stages.

Conclusions:

  • The management of acute ischemic stroke is rapidly evolving.
  • Clinicians must stay updated on new therapeutic strategies.
  • Further research is needed to validate emerging treatments for cerebral ischemia.